fda removes tirzepatide from shortage list Lilly's weight-loss drug removed FDA's ๐จ Alert: Tirzepatide No Longer
Description
Discover the benefits of semaglutide injections for weight loss at Thrive Aesthetic & Wellness
Recently, the introduction of highly effective glucagon-like peptide-1 (GLP-1) receptor agonists has led to increased utilization of obesity medications in this population

Eli Lilly reported another success in a study pitting its once-daily oral GLP-1 therapy Orforglipron against a competing type 2 DM therapy, this time AstraZeneca's SGLT2I Farxiga (Dapagliflozin)

Learn about hydration risks, drug interactions, and when to pause your dose for a safe recovery.
